Leukemia, Myelocytic, Acute
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
E-AML was associated with BCOR/BCORL1 mutations and HOX gene overexpression.
|
30480765 |
2019 |
Leukemia, Myelocytic, Acute
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
In cases of AML that are FLT3-ITD-negative, aged 65 years or below, and in the intermediate cytogenetic prognosis group, which are considered to have relatively favorable prognosis, BCOR gene mutations appear to be an important prognostic factor.
|
29663558 |
2018 |
Leukemia, Myelocytic, Acute
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
A search for the second hit which led to the development of MDS and later AML in this individual revealed the PHF6 gene variant (exon9:c.872G > A:p.G291E; NM_001015877), BCORL1 (exon3:c.1111A > C:p.T371P; NM_001184772) and BCOR gene variant (exon4:c.2076dupT:p.P693fs; NM_001123383), which appear to be very likely second hits participating in the progression to myeloid malignancy.
|
30083851 |
2018 |
Leukemia, Myelocytic, Acute
|
0.370 |
AlteredExpression
|
disease |
BEFREE |
Global RNA expression profiling in murine cells and AML patient samples with BCOR loss-of-function mutation suggested that loss of BCOR expression is associated with enhanced cell proliferation and myeloid differentiation.
|
26847029 |
2016 |
Leukemia, Myelocytic, Acute
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
In addition, massively parallel sequencing has identified inactivating somatic BCOR and BCORL1 mutations in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia, medulloblastoma, and retinoblastoma.
|
24515802 |
2014 |
Leukemia, Myelocytic, Acute
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
In univariate analysis, BCOR mutations were associated with poor prognosis in MDS (overall survival [OS]: P = .013; cumulative incidence of AML transformation: P = .005).
|
24047651 |
2013 |
Leukemia, Myelocytic, Acute
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Further analyses of 553 AML patients showed that BCOR mutations occurred in 3.8% of unselected CN-AML patients and represented a substantial fraction (17.1%) of CN-AML patients showing the same genotype as the AML index patient subjected to whole-exome sequencing.
|
22012066 |
2011 |
Leukemia, Myelocytic, Acute
|
0.370 |
CausalMutation
|
disease |
CGI |
|
|
|